



2010, Vol. 17, No. 2, pp. 157–162
Copyright © 2010 Via Medica
ISSN 1897–5593
Address for correspondence: Maciej Kostrubiec, MD, PhD, Department of Internal Medicine and Cardiology, The Medical
University of Warsaw, Lindleya 4, 02–005 Warszawa, Poland, tel: +48 22 502 11 44, fax: +48 22 502 21 42,
e-mail: maciej.kostrubiec@wum.edu.pl
Received: 20.06.2009 Accepted: 7.09.2009
Signs of myocardial ischemia on
electrocardiogram correlate with elevated
plasma cardiac troponin and right ventricular
systolic dysfunction in acute pulmonary embolism
Maciej Kostrubiec, Krzysztof Jankowski, Justyna Pedowska-Włoszek,
Blanka Puncewicz, Szymon Pacho, Barbara Lichodziejewska,
Andrzej Łabyk, Anna Hrynkiewicz-Szymańska, Piotr Pruszczyk
Department of Internal Medicine and Cardiology, The Medical University of Warsaw, Poland
Abstract
Background: Plasma cardiac troponins (cTn) are frequently elevated in acute pulmonary
embolism (APE). ST-segment abnormalities on electrocardiography are also commonly ob-
served in APE patients. However, it has not been defined which ventricle is a potential source
of cTn release. We assessed the potential relationship between electrocardiographic signs of
myocardial ischemia, systolic dysfunction of both ventricles at echocardiography and cTn levels
in APE.
Methods: We evaluated 94 consecutive patients (42 male, 52 female, aged 63 ± 19 years)
with APE. On admission, blood samples were collected for cTnI or cTnT and standard
12-lead electrocardiogram was performed. The following signs of myocardial ischemia were
analyzed: T-wave inversion [T (–)] and ST-depression or elevation (≥ 1 mV, at ≥ 2 leads).
The assessment of systolic function of both ventricles was performed by echocardiography.
Results: In 33 (35%) patients, cTn exceeded the upper reference limit of our laboratory. The
history of coronary artery disease (27% vs. 31%) and previous myocardial infarction (12% vs.
10%) did not differ in patients with elevated cTn [cTn (+)] and non-elevated cTn [cTn (–)].
In cTn (+) group T (–) or ST-depression were observed more frequently than in cTn (–)
[32 (97%) vs. 46 (75%), p < 0.01]. However, both groups presented similar frequency of
ST-elevation [7 (21%) vs. 11 (18%), p = NS). Interestingly, cTn levels correlated with the
number of leads with T (–) or ST-depression (R = 0.30, p < 0.01). Moreover, in cTn (+) group
right ventricular systolic dysfunction was more frequent [15 (54%) vs. 4 (7%), p = 0.0001],
while left ventricle contractility abnormalities occurred similarly in both groups [3 (11%) vs.
8 (15%), p = NS].
Conclusions: Signs of myocardial ischemia (ST-segment changes) on electrocardiography in
APE correlate with an elevated cTn and with the impairment of right, but not left, ventricle
systolic function at echocardiography. (Cardiol J 2010; 17, 2: 157–162)
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Introduction
The electrocardiographic (ECG) signs of pul-
monary embolism are well described. They include
T-wave inversion, ST-segment depression or ele-
vation (pseudoinfarction), an S1Q3T3 or S1S2S3 pat-
tern; complete or incomplete right bundle-branch
block; and sinus tachycardia [1–3]. It can be as-
sumed that the ECG findings in acute pulmonary
embolism (APE) resulted from myocardial ischemia
and/or increased right ventricular (RV) wall stress.
Cardiac troponin (cTn) levels of both troponin I and
T are frequently elevated in APE. Furthermore, tro-
ponins are accepted markers of increased risk of
short-term mortality and other adverse outcomes,
even regardless applied assay and cutoff value [4–6].
It has not been defined which ventricle is
a potential source of cTn release. Therefore, we
tried to assess the relationship between signs of
myocardial ischemia at ECG, systolic dysfunction
of both ventricles at echocardiography and plasma




The study population comprised consecutive
patients with APE diagnosed and treated in our
department. APE was confirmed by contrast-en-
hanced spiral computed tomography (16 MSCT, GE
Bright Speed ‘G’) showing thromboemboli at least
in segmental arteries. APE was diagnosed when
symptoms of pulmonary embolism before the
diagnosis lasted no longer than 14 days. On
admission, clinical data and blood samples were
collected. Echocardiography and standard ECG
were performed within the first 24 hours after the
diagnosis. Severity of APE was assessed according
to current European Cardiac Society guidelines [7].
Patients with shock or hypotension formed a high
risk group. The intermediate risk group included
patients with RV overload at echocardiography and
a positive troponin test, while the remaining
patients without RV overload or signs of myocardial
injury formed a low risk group.
The protocol of this study was approved by the
local Bioethical Committee.
Biochemical assays
On admission, venous blood samples were col-
lected for routine assays and for plasma cardiac tro-
ponin I or T (troponin T was assayed with ELECSYS,
Roche and troponin I with Dimension® RxL, Dade
Behring). Plasma levels of cTnT > 0.03 µg/L and
cTnI > 0.07 µg/L indicated myocardial injury and
were considered a ‘positive’ test. The physicians
evaluating the echocardiography were unaware of
troponin results.
Electrocardiography analysis
Original ECG tracings were analyzed independ-
ently by two experienced cardiologists who were
unaware of the patients’ history, laboratory and
echocardiographic results. The following ECG ab-
normalities suggestive of myocardial ischemia were
evaluated [8]: T-wave inversion (≥ 1 mV), ST-de-
pression or elevation (≥ 1 mV), at least in two con-
tiguous leads [9]; right bundle branch block (QRS
> 0.11 s and S wave in lead I and terminal R wave
in V1 with amplitude > 0.15 mV); S1S2S3 pattern
(S wave in leads I, II and III with amplitude > 0.15 mV)
or S1Q3T3 pattern (S wave in lead I and Q wave in
lead III with amplitude > 0.15 mV, associated with
T-wave inversion in lead III). Leads I, aVL and V5,
V6 were considered as lateral leads, II, III and aVL
inferior and V1–V4 anterior ones.
Echocardiography
Transthoracic echocardiography (TTE) for the
assessment of ventricular systolic abnormalities
and RV overload was performed using a Philips iE33
echocardiographic system (Bothell, WA, USA). The
examinations were digitally recorded by an experi-
enced echocardiographer blinded to biochemical and
ECG results. Right ventricular overload was diag-
nosed when echocardiography showed RV/LV > 0.6
with RV free wall hypokinesis, and/or elevated tri-
cuspid valve pressure gradient exceeding 30 mm Hg
with a shortened acceleration time of pulmonary
ejection below 80 ms.
Right ventricular systolic function was as-
sessed quantitatively. Hypokinesis of RV free wall
was reported. Segmental analysis of left ventricu-
lar (LV) systolic function was performed. The 17 se-
gments eligible for analysis were assessed as
normokinetic, hypokinetic, akinetic or dyskinetic
[10]. Left ventricular systolic dysfunction was dia-
gnosed when abnormalities affected at least one
segment.
Statistical analysis
Data characterized by a normal distribution is
expressed as mean followed by the standard devia-
tion. Parameters without such distribution are ex-
pressed as a median with a range. Student’s or
Mann-Whitney’s tests were used for comparing the
two groups. The c2 test was used to compare dis-
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crete variables. The dependent variables were com-
pared by Friedman ANOVA or Wilcoxon matched
pairs test. All tests were two-sided. Data was considered
significant at p < 0.05. STATISTICA software (StatSoft,
Inc. 2008) was used for statistical calculations.
Results
Patients’ characteristics
The study included 94 consecutive patients
with APE, 42 males and 52 females aged 63 ± 19
years (Table 1). Clinically high-risk APE was diag-
nosed in five patients, while the remaining 89 pa-
tients were normotensive on admission. Low risk
APE was found in 34 patients, while 51 normoten-
sive cases with right ventricular dysfunction at
echocardiography and four people with elevated cTn
formed an intermediate risk subgroup [7].
Cardiac troponin
In 33 (35%) patients cTn indicated myocardial
injury. Elevated troponin levels were found in four
of five (80%) high risk patients and in 29 of 55
(53%) intermediate risk cases. The frequency of
coronary artery disease (27% vs. 31%) and previ-
ous myocardial infarction (12% vs. 10%) did not
differ between patients with elevated cTn and non-
-elevated cTn.
ECG analysis
ECG signs of myocardial ischemia were
present in all five (100%) high risk patients,
49 (86%) with intermediate risk and in 27 (75%) low
risk cases. In the group with elevated cTn, nega-
tive T-waves or ST-depression were observed sig-
nificantly more often than in patients without myo-
cardial injury, 32 (97%) vs. 46 (75%), p < 0.01;
number of leads with negative T or ST-depression
2.9 ± 1.4 vs. 1.8 ± 1.5, p < 0.001, respectively. The
most infrequent ST-segment changes were found
at lateral leads, 39 (41%) patients. Negative T-
-waves or ST-depressions in inferior leads were
found in 54 (57%) patients, while in anterior leads
they appeared in 63 (67%; Table 1). It should be
underlined that ST changes were more frequent in
patients with elevated cTn than in cTnT (–) group
[lateral leads 20 (61%) vs. 19 (31%), p < 0.01; infe-
rior leads 25 (76%) vs. 29 (48%), p = 0.01; anterior
leads 28 (85%) vs. 35 (57%), p = 0.01; respectively].
Moreover, elevated cTn correlated with the number
of leads with negative T-wave or ST-depression
(R = 0.30, p < 0.01).
Table 1. Patient characteristics according to plasma troponin levels.
All patients (n = 94) cTn (–) (n = 61) cTn (+) (n = 33) p
Age (years) 63 ± 19 62 ± 21 67 ± 16 NS
Sex (male/female) 42 (45%)/52 (55%) 27 (44%)/34 (56%) 15 (45%)/18 (55%) NS
Heart rate [bpm] 95 ± 26 94 ± 24 98 ± 30 NS
Left/right axis deviation 29 (31%)/8 (8%) 17 (28%)/3 (5%) 12 (36%)/5 (15%) NS
Right bundle branch block 21 (22%) 8 (13%) 13 (39%) 0.01
S1Q3T3 19 (20%) 7 (11%) 12 (36%) < 0.01
T (–) or ST depression 39 (41%) 19 (31%) 20 (61%) < 0.01
in lateral leads (I, aVL, V5, V6)
T (–) or ST depression 54 (57%) 29 (48%) 25 (76%) 0.01
in inferior leads (II, III, aVF)
T (–) or ST depression 63 (67%) 35 (57%) 28 (85%) 0.01
in anterior leads (V1–V4)
Number of lead with T (–) 2.1 ± 1.6 1.8 ± 1.5 2.9 ± 1.4 < 0.001
or ST-depression
ST-segment elevation 18 (19%) 11 (18%) 7 (21%) NS
LVSD (n = 87) 11 (13%) 8 (14%)# 3 (11%)* NS
RVSD (n = 87) 19 (22%) 4 (7%)# 15 (54%)* 0.0001
RV overload 54 (57%) 27 (44%) 27 (82%) 0.001
*n = 28, #n = 59; LVSD — left ventricular systolic dysfunction; RVSD — right ventricular systolic dysfunction; cTn (–) — non-elevated cTn;
cTn (+) — elevated cTn, T (–) — T wave inversion; S1Q3T3 — S wave in lead I and Q in III and T wave inversion in III
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Echocardiography
Image quality allowed assessment of the systo-
lic function of both ventricles in 87 (93%) patients.
Left ventricular regional contractility abnormalities
were present in 11 (13%) patients and varied from
hypokinesia of one segment to profound abnormal-
ities affecting 11 segments. Global LV systolic dys-
function was found in one (1%) case (ejection frac-
tion 40%). There was no difference in the frequen-
cy of LV contractility abnormalities between
patients with elevated and non-elevated cTn
(Table 1). RV overload was found in 54 (57%) patients.
RV contractility abnormalities were present in
19 (22%) cases. Fifteen (79%) patients had only
hypokinesis of the free wall (McConnell sign), while
the systolic dyfunction of both free wall and apical
segments was noted in four (21%) cases. RV
overload and RV contractility abnormalities were
significantly more frequent in patients with elevated
cTn [27 (82%) vs. 27 (44%), p = 0.001 and 15 (50%)
vs. 4 (7%), p = 0.0001, respectively].
Only one patient with regional LV contractili-
ty abnormalities on echocardiography presented
negative T-waves and ST-segment depression. All
patients with RV systolic dysfunction had negative
T-waves or ST-depression in at least two contigu-
ous leads, while there was normal RV systolic func-
tion in 16 (23%) cases without any signs of ischemia
on ECG (p = 0.02). Both RV contractility abnormal-
ities and negative T-waves or ST-depression in at
least two contiguous leads were found in 15 (54%)
patients with elevated cTn (Fig. 1). There was nor-
mal RV systolic function and no signs of ischemia
on ECG in the group of 15 (27%) patients with un-
elevated cTn levels. Interestingly, only one patient
with elevated cTn had normal RV systolic function
and no signs of ischemia on ECG; however the RV
overload was noticed.
ST-segment elevation
ST-segment elevation of more than or equal to
1 mV in at least two contiguous leads was present
in 18 (19%) patients. Seven of these presented el-
evated cTn levels, while the other 11 cases showed
no biochemical signs of myocardial injury (p = NS).
ST-segment elevation was found in anterior leads
in 17 (94%) patients and in one case with simulta-
neous elevation in lateral leads. One patient had
ST-segment elevation in inferior leads. ST-segment
elevation was present in two (40%) high risk pa-
tients, eight (15%) with intermediate risk and in
eight (24%) low risk cases. Interestingly, ST-seg-
ment elevation was present on ECG of four patients
with a history of coronary heart disease or myocar-
dial infarction and on ECG of 12 patients without
such a history. In only one (5%) patient with RV
contractility abnormalities was ST-segment eleva-
tion found, while it was noticed in five (45%) with
LV systolic dysfunction (p < 0.05). Interestingly,
ten (56%) patients with ST-segment elevation had
no detectable RV nor LV systolic dysfunction, in-
cluding two cases with elevated cTn and other signs
of RV overload. There was no correlation between
the extent of LV systolic dysfunction and signs of
myocardial injury.
Discussion
A physiological explanation of ECG abnormal-
ities associated with acute pulmonary embolism
remains difficult to define [11]. When the levels of
biomarkers of cardiac injury and ischemia were
found to be increased in some patients with APE
[4, 5], myocardial injury of RV was suggested to be
a potential cause of cTn release. However, studies
on animal models showed that RV failure during
pulmonary artery constriction develops in spite of
increased coronary blood flow and RV oxygen con-
sumption [12]. Thus, mechanisms different from
ischemia may contribute to progressive RV failure
and myocardial injury after pulmonary embolism.
The study based on creatine kinase assess-
ment, a less sensitive biomarker of myocardial in-
jury, and scintigraphy, failed to demonstrate une-
quivocal evidence of ischemia in patients with
T-wave changes over the anterior precordial leads
[11, 13]. However, elevations of creatine kinase that
Figure 1. Number of patients with acute pulmonary em-
bolism and troponin (cTn) elevation, right ventricle (RV)
systolic dysfunction and negative T wave or ST-seg-
ment depression (n = 87); *patient with RV overload.
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met enzyme criteria of acute infarction were report-
ed in 7.7% of patients with pulmonary emboli and
absence of known ischemic heart disease [14]. In
our group, all patients with RV systolic dysfunction
showed negative T-wave in the precordial leads.
Importantly, all of them had preserved left ventricu-
lar systolic function.
Moreover, signs of myocardial ischemia on
ECG commonly observed in acute pulmonary em-
bolism, were also suggested to be a useful, simple,
inexpensive tool for initial risk stratification of pa-
tients with acute major pulmonary embolism [15, 16].
In our study, the presence of ECG signs of myocar-
dial ischemia in all high risk patients, and 86% with
intermediate risk, seems to confirm such reports.
Also, cardiac troponins frequently elevated in
APE were found to be associated with short-term
death and other adverse outcomes [4, 5]. The prog-
nostic value of troponin was consistent for both tro-
ponin I and T and allowed the identification of a high
risk group even among patients hemodynamically
stable on admission [6].
Coronary angiography was reported to be per-
formed in some patients with APE. Despite symp-
toms suggestive of acute coronary syndrome, with
co-existing electrocardiographic abnormalities and
elevated troponin levels, unchanged coronary ves-
sels were eventually visualized [17–19] Some au-
thors suggest that morphology of negative T-waves
and their appearance in particular leads (III and V1)
allows the differentiation between APE and acute
coronary syndrome in patients with negative
T-waves in the precordial leads [20, 21].
In our study, ST-segment abnormalities (ne-
gative T-waves or ST-segment depression) were the
most frequent in anterior leads (67% patients with
APE). ST-segment changes appeared more often in
patients with elevated cTn than in patients with
normal levels. Moreover, elevated cTn correlated
with the number of leads with negative T-wave or
ST-segment depression. These results suggest that
myocardial injury caused by acute RV overload
manifests on ECG as negative T-waves or ST-seg-
ment depression. Moreover, elevated cTn in APE
seems to correspond with the extent of myocardial
ischemia on ECG.
RV overload was noticed in 82% of patients
with elevated cTn, and RV contractility abnormali-
ties were present in 50% of them. All patients with
RV contractility abnormalities had negative T-waves
or ST-segment depression in at least two contigu-
ous leads, while only one (9%) patient with LV sys-
tolic dysfunction in echocardiography had negative
T waves or ST-segment depression. Such observa-
tions indicate that ECG changes are probably
caused by injury to the right ventricle. The cause
of ST-segment elevation in APE seems to be more
complex and can result from the pre-existing LV
systolic dysfunction, RV overload with cTn release
or a combination of the above.
In our study the S1Q3T3 pattern; S1S2S3 pattern;
complete or incomplete right bundle-branch block;
and sinus tachycardia were not associated with cTn
elevation or RV contractility abnormalities.
The main limitation of our study is the fact that
it is a single center study. The diagnosis of APE
depended on a spiral computed tomography, and so
other pulmonary embolism, perhaps with different
characteristics, could have been missed. In some
patients we had results of troponin T, while in
others results of troponin I. However both were
reported as having a similar prognostic value [4].
Moreover, we could not exclude the pre-existing
RV or LV systolic dysfunction before the current
episode of APE. In our study, due to lack of coronary
angiography data, we cannot definitely exclude the
significant occlusion of coronary vessels, especially
in patients with ST-segment elevation and elevated
cTn. However, in most of them, normal LV systolic
function and RV overload typical for APE was
confirmed on echocardiograhpy. The only patient
with ST-segment elevation, LV contractility
abnormalities and positive cTn had also significant
RV overload. We should also remember that in the
PRAGUE trial the observed prevalence of normal
coronary angiography in patients presenting with
acute chest pain and ST-elevations was 2.6% [19].
Among these, the diagnosis of pulmonary embolism
at discharge was also made.
Conclusions
In acute pulmonary embolism, signs of myocar-
dial ischemia on ECG correlate with an elevated
cardiac troponin and with the impairment of right
(but not left) ventricle contractility at echocardio-
graphy. Moreover, elevation of cardiac troponin
seems to be related to the extent of changes of ST
segment on ECG.
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